GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 744 filers reported holding GLAXOSMITHKLINE PLC in Q3 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $22,000 | -4.3% | 550 | 0.0% | 0.03% | -16.1% |
| Q1 2019 | $23,000 | +9.5% | 550 | 0.0% | 0.03% | -22.5% |
| Q4 2018 | $21,000 | -4.5% | 550 | 0.0% | 0.04% | +81.8% |
| Q3 2018 | $22,000 | 0.0% | 550 | 0.0% | 0.02% | -4.3% |
| Q2 2018 | $22,000 | +4.8% | 550 | 0.0% | 0.02% | -4.2% |
| Q1 2018 | $21,000 | +5.0% | 550 | 0.0% | 0.02% | +4.3% |
| Q4 2017 | $20,000 | -57.4% | 550 | -52.2% | 0.02% | -58.9% |
| Q3 2017 | $47,000 | -99.9% | 1,150 | 0.0% | 0.06% | -1.8% |
| Q2 2017 | $49,588,000 | +488.1% | 1,150 | +475.0% | 0.06% | +470.0% |
| Q1 2017 | $8,432,000 | +9.5% | 200 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $7,703,000 | -45.0% | 200 | -38.5% | 0.01% | -55.6% |
| Q3 2016 | $14,017,000 | -0.5% | 325 | 0.0% | 0.02% | 0.0% |
| Q2 2016 | $14,086,000 | -70.2% | 325 | -72.1% | 0.02% | -71.9% |
| Q1 2016 | $47,241,000 | +0.5% | 1,165 | 0.0% | 0.06% | +8.5% |
| Q4 2015 | $47,008,000 | +4.9% | 1,165 | 0.0% | 0.06% | +1.7% |
| Q3 2015 | $44,794,000 | -16.6% | 1,165 | -9.7% | 0.06% | -4.9% |
| Q2 2015 | $53,729,000 | -9.8% | 1,290 | 0.0% | 0.06% | -16.4% |
| Q1 2015 | $59,534,000 | +19.6% | 1,290 | +10.7% | 0.07% | +12.3% |
| Q4 2014 | $49,792,000 | – | 1,165 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |